NUS — NU Skin Enterprises Income Statement
0.000.00%
Last trade - 00:00
- $380.22m
- $605.62m
- $1.97bn
- 86
- 95
- 35
- 83
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 2,420 | 2,582 | 2,696 | 2,226 | 1,969 |
Cost of Revenue | |||||
Gross Profit | 1,839 | 1,924 | 2,020 | 1,595 | 1,357 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 2,153 | 2,324 | 2,462 | 2,115 | 1,921 |
Operating Profit | 267 | 258 | 234 | 111 | 48.3 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 255 | 256 | 232 | 89 | 26.6 |
Provision for Income Taxes | |||||
Net Income After Taxes | 174 | 191 | 147 | 105 | 8.6 |
Net Income Before Extraordinary Items | |||||
Net Income | 174 | 191 | 147 | 105 | 8.6 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 174 | 191 | 147 | 105 | 8.6 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 3.1 | 3.63 | 3.5 | 2.7 | 0.43 |
Dividends per Share |